Testing effectiveness (Phase 2)Study completedNCT01171209
What this trial is testing
REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients
Who this might be right for
Multiple Sclerosis
Melinda Magyari 10